Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. (Q54048009)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. |
scientific article |
Statements
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. (English)
1 reference
E Vokes
1 reference
F V Fossella
1 reference
R DeVore
1 reference
R N Kerr
1 reference
J Crawford
1 reference
R R Natale
1 reference
F Dunphy
1 reference
L Kalman
1 reference
V Miller
1 reference
J S Lee
1 reference
M Moore
1 reference
D Gandara
1 reference
D Karp
1 reference
M Kris
1 reference
Y Kim
1 reference
F Gamza
1 reference
L Hammershaimb
1 reference
1 June 2000
1 reference
18
1 reference
12
1 reference
2354-2362
1 reference
Identifiers
1 reference